Search Results - "Kockelbergh, Roger"

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer by Hamdy, Freddie C, Donovan, Jenny L, Lane, J. Athene, Mason, Malcolm, Metcalfe, Chris, Holding, Peter, Davis, Michael, Peters, Tim J, Turner, Emma L, Martin, Richard M, Oxley, Jon, Robinson, Mary, Staffurth, John, Walsh, Eleanor, Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Powell, Philip, Prescott, Stephen, Rosario, Derek J, Rowe, Edward, Neal, David E

“…In the ProtecT trial, over 1600 men with PSA-detected localized prostate cancer were assigned to active monitoring, prostatectomy, or radiotherapy. Although…”
Get full text

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer by Donovan, Jenny L, Hamdy, Freddie C, Lane, J. Athene, Mason, Malcolm, Metcalfe, Chris, Walsh, Eleanor, Blazeby, Jane M, Peters, Tim J, Holding, Peter, Bonnington, Susan, Lennon, Teresa, Bradshaw, Lynne, Cooper, Deborah, Herbert, Phillipa, Howson, Joanne, Jones, Amanda, Lyons, Norma, Salter, Elizabeth, Thompson, Pauline, Tidball, Sarah, Blaikie, Jan, Gray, Catherine, Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Powell, Philip, Prescott, Stephen, Rosario, Derek J, Rowe, Edward, Davis, Michael, Turner, Emma L, Martin, Richard M, Neal, David E

“…The choice of treatment for PSA-detected, localized prostate cancer is influenced by effects of the interventions on quality of life. In the ProtecT trial,…”
Get full text

Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes by Burge, Frances, Kockelbergh, Roger

“…Despite recent attention, there are no gender specific guidelines to address the disparity in bladder cancer survival between the sexes. The focus of this…”
Get more information

Patient experience of bladder cancer: A data linkage study by Shah, Snehadhar, Ince, Jonathan, Kockelbergh, Roger

“…Introduction Bladder cancer is one of the most common cancers worldwide and can be managed with a range of approaches, including conservative, medical and…”
Get full text

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT by Hamdy, Freddie C, Donovan, Jenny L, Lane, J Athene, Mason, Malcolm, Metcalfe, Chris, Holding, Peter, Wade, Julia, Noble, Sian, Garfield, Kirsty, Young, Grace, Davis, Michael, Peters, Tim J, Turner, Emma L, Martin, Richard M, Oxley, Jon, Robinson, Mary, Staffurth, John, Walsh, Eleanor, Blazeby, Jane, Bryant, Richard, Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Powell, Philip, Prescott, Stephen, Rosario, Derek, Rowe, Edward, Neal, David

“…Prostate cancer is the most common cancer among men in the UK. Prostate-specific antigen testing followed by biopsy leads to overdetection, overtreatment as…”
Get full text

The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer by Noble, Sian M., Garfield, Kirsty, Lane, J. Athene, Metcalfe, Chris, Davis, Michael, Walsh, Eleanor I., Martin, Richard M., Turner, Emma L., Peters, Tim J., Thorn, Joanna C., Mason, Malcolm, Bollina, Prasad, Catto, James W. F., Doherty, Alan, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Rosario, Derek J., Rowe, Edward, Oxley, Jon, Staffurth, John, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L.

“…Background There is limited evidence relating to the cost-effectiveness of treatments for localised prostate cancer. Methods The cost-effectiveness of active…”
Get full text

Continent urinary diversion and management of pouch calculi as a late complication: A case series by Ball, Kathryn, Warner, Ross M, Douglas-Moore, Jayne L, Khan, Masood A, Mellon, J Killian, Kockelbergh, Roger C

“…Objective: Following cystectomy, there are several reconstructive options. A continent cutaneous urinary diversion (CUD) avoids an ileal conduit if patients…”
Get full text

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09) by Langley, Ruth E, Dr, Cafferty, Fay H, PhD, Alhasso, Abdulla A, FRCR, Rosen, Stuart D, MD, Sundaram, Subramanian Kanaga, FRCS, Freeman, Suzanne C, MSc, Pollock, Philip, MRes, Jinks, Rachel C, PhD, Godsland, Ian F, PhD, Kockelbergh, Roger, FRCS(Urol), Clarke, Noel W, Prof, Kynaston, Howard G, Prof, Parmar, Mahesh KB, Prof, Abel, Paul D, Prof

“…Summary Background Luteinising-hormone-releasing-hormone agonists (LHRHa) to treat prostate cancer are associated with long-term toxic effects, including…”
Get full text

Testicular Surveillance Post-Orchidopexy and its Impact on Early Diagnosis of Testicular Cancer by Mohamed, Ahmed Osama, Murtagh, Kevin, Kockelbergh, Roger, ElMalik, Khalid

“…Paediatric surgeons are expected to counsel patients about the potential risk of cancer post-orchidopexy and the need to self-examine in adulthood. The study…”
Get full text

A cut above? Inferior vena cava resection without reconstruction: a dual-centre experience by Noël, Jonathan P, Tang, Sarah Yu Weng, Muhammad, Nana Aishatu Liman, Nicol, David, Kockelbergh, Roger C

“…Objectives: To evaluate outcomes in our patients undergoing inferior vena cava (IVC) resection without reconstruction, as part of an adrenal/renal cell cancer…”
Get full text

A Green Light for Blue Light … Without Single-dose Chemotherapy by Griffiths, T.R. Leyshon, Kockelbergh, Roger C

Get full text

Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial by Wade, Julia, Donovan, Jenny, Lane, Athene, Davis, Michael, Walsh, Eleanor, Neal, David, Turner, Emma, Martin, Richard, Metcalfe, Chris, Peters, Tim, Hamdy, Freddie, Kockelbergh, Roger, Catto, James, Paul, Alan, Holding, Peter, Rosario, Derek, Kynaston, Howard, Rowe, Edward, Hughes, Owen, Bollina, Prasad, Gillatt, David, Doherty, Alan, Gnanapragasam, Vincent J, Paez, Edgar

“…Active surveillance (AS) enables men with low risk, localised prostate cancer (PCa) to avoid radical treatment unless progression occurs; lack of reliable AS…”
Get full text

Immunocytochemical detection of ERG expression in exfoliated urinary cells identifies with high specificity patients with prostate cancer by Pal, Raj P., Kockelbergh, Roger C., Pringle, John Howard, Cresswell, Lara, Hew, Roger, Dormer, John P., Cooper, Colin, Mellon, John Kilian, Barwell, Julian G., Hollox, Edward J.

“…Objectives To evaluate the immunocytochemical detection of ERG protein in exfoliated cells as a means of identifying patients with prostate cancer (PCa) before…”
Get full text

Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo by Bowman, Karen J., Al‐Moneef, Manar M., Sherwood, Benedict T., Colquhoun, Alexandra J., Goddard, Jonathan C., Griffiths, T.R. Leyshon, Payne, David, Singh, Sadmeet, Butterworth, Paul C., Khan, Masood A., Summerton, Duncan J., Steward, William P., McKelvey‐Martin, Valerie J., McKeown, Stephanie R., Kockelbergh, Roger C., Mellon, J. Kilian, Symonds, R. Paul, Jones, George D.D.

“…Bladder cancer patients suffer significant treatment failure, including high rates of recurrence and poor outcomes for advanced disease. If mechanisms to…”
Get full text

The experience of UK patients with bladder cancer during the second wave of the COVID‐19 pandemic by Russell, Beth, Spencer‐Bowdage, Sarah, Rigby, Jeannie, O'Kelly, Jackie, Kelly, Phil, Page, Mark, Raw, Caroline, Allchorne, Paula, Harper, Peter, Crew, Jeremy, Kockelbergh, Roger, Knight, Allen, Van Hemelrijck, Mieke, Bryan, Richard T.

“…Data were predominantly analysed descriptively; chi-squared and Fisher's exact tests were conducted to compare changes to treatment and monitoring due to…”
Get full text

Microvessel Density at Presentation Predicts Subsequent Muscle Invasion in Superficial Bladder Cancer by GODDARD, Jonathan C, SUTTON, Christopher D, FURNESS, Peter N, O'BYRNE, Kenneth J, KOCKELBERGH, Roger C

“…Purpose: The purpose of this study was to determine whether angiogenesis, as measured by microvessel density (MVD), at presentation is related to subsequent…”
Get full text

The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer by Jain, Sunjay, Kockelbergh, Roger C.

Get full text

The prostate care questionnaire for patients (PCQ-P): reliability, validity and acceptability by Tarrant, Carolyn, Baker, Richard, Colman, Andrew M, Sinfield, Paul, Agarwal, Shona, Mellon, John K, Steward, William, Kockelbergh, Roger

“…In England, prostate cancer patients report worse experience of care than patients with other cancers. However, no standard measure of patient experience of…”
Get full text

Utility of renal mass biopsy in a UK tertiary referral centre by Walton, Thomas J, Amery, Carolyn, Moore, David, Mayer, Nicholas J, Rajesh, Arumugam, Kockelbergh, Roger C

“…Abstract Objective To determine the value of percutaneous biopsy in a UK cohort of patients with renal mass lesions, with particular reference to its utility…”
Get full text

Renal Tumour Biopsy – A New Standard of Care? by Kockelbergh, Roger, Griffiths, Leyshon

Get full text